TOMM34

Across TCGA pan-cancer cohorts, TOMM34 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TOMM34 data layer compared with 26 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher TOMM34 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TOMM34 expression acts as an unfavorable survival marker.

OV, BLCA, and SKCM are the cancer types where TOMM34 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	II,III,IV	0.182	0.541	.011	30	view →
BLCA	DFS	Median	All	0.122	0.626	.001	18	view →
SKCM	OS	Median	All	0.179	0.781	<.001	15	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TOMM34–OV (DFS)

Open the OV breakdown →